PHARMACEUTICAL LAW PUBLICATION nº 76

Interruption of supply or the withdrawal of medicines from the market and competition rules.

Henar González Durántez y Pilar Carrasco del Olmo

 

2021 versión of Pharmaceutical Industry Code  of Best Practices.

Teresa Paz-Ares Rodríguez, Beatriz Cocina Arrieta y Nuria Porxas Roig

 

Regulatory framework aplicable to observational studies with medicines for human use foreseen in Royal Decree 957/2020 and the impact on the regimen aplicable  to patient support programs.

Jordi Faus Santasusana y Lluís Alcover Llubià

 

Civil liability regime for defective products in case of damages caused by mass vaccination

Kiko Carrión García de Parada

 

Possibility of establishing a Compensation Fund in Spain to compensate COVID-19 vaccine damages.

Paulino Fajardo Martos, Lourdes Fraguas Gadea y Milagros Sanz Parrilla

 

Vaccines in pandemic time.

Fundación CEFI

 

Click here to access the publication

This post is also available in: Spanish

Otras noticias

Promotion of Research through IP protection

Three of the most recognized experts on IP farma in Spain Ángel García Vidal, profesor de Derecho Mercantil de la Universidad de Santiago de Compostela y Consejero Académico de Gómez Acebo y Pombo, Kiko Carrión García de Parada, Abogado socio

Leer Más >>

Clinical Research and data protection debate

Interesting debate with Jesús Rubí, Adjunto a la Dirección de la Agencia Española de Protección de Datos, Amelia Martín Uranga, Responsable de la Plataforma de Medicamentos Innovadores de Farmaindustria and Lluis Alcover, Abogado de Faus y Moliner. Interestingf debate about main

Leer Más >>